Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,094 followers.

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC https://t.co/AHx7YQljbh https://t.co/M7YqV9FNvF

19 Jan 2023

Reply Repost Favourite

New Research: Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC: Background Toripalimab shows antitumor efficacy in cholangiocarcinoma. Radiotherapy (RT) may enhance systemic responses of PD-1… https://t.co

17 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.